RELX Investor Presentation Deck slide image

RELX Investor Presentation Deck

Databases and tools example 48% ClinicalPath of care aligned with nationally accepted cancer guidelines Adapted from 2021 product demo 80%+ of care is on pathway with ClinicalPath use Who we serve: oncology service line leaders Problems we address: reducing unwarranted variability in care and enabling appropriate use of precision oncology Our offering: comprehensive set of medical and radiation oncology pathways, covering 95%+ of cancer presentations Our footprint: in the US, used by 15% of all oncologists, growing global footprint & RELX 34
View entire presentation